Subject(s)
Buprenorphine/administration & dosage , Narcotic Antagonists/administration & dosage , Opioid-Related Disorders/rehabilitation , Delayed-Action Preparations , Drug Approval , Drug Implants , Humans , Opiate Substitution Treatment/methods , United States , United States Food and Drug AdministrationSubject(s)
Antidepressive Agents, Second-Generation/pharmacology , Antidepressive Agents, Second-Generation/therapeutic use , Depression/drug therapy , Depression/nursing , Selective Serotonin Reuptake Inhibitors/pharmacology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adolescent , Adult , Aged , Antidepressive Agents, Second-Generation/adverse effects , Antidepressive Agents, Second-Generation/pharmacokinetics , Child , Depression/physiopathology , Fibromyalgia/drug therapy , Headache/etiology , Health Knowledge, Attitudes, Practice , Humans , Liver Cirrhosis , Middle Aged , Migraine Disorders/drug therapy , Neurons/metabolism , Off-Label Use , Panic Disorder/drug therapy , Phobia, Social/drug therapy , Psychotherapy , Serotonin/metabolism , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/pharmacokinetics , Suicidal Ideation , Synapses/metabolism , Young AdultABSTRACT
Recovery is a continuous, progressive process of improvement whereby a person with a substance use disorder first becomes sober and then begins a lifelong commitment to improve his or her health, live a self-directed life, and strive to reach full potential. The nurse plays an important role in the beginning stages of this process by helping the patient identify relapse risk factors along with providing psychoeducational, psychotherapeutic, and psychopharmacologic interventions to decrease the risk of relapse and direct the patient down a path of self-efficacy, personal health, and productive citizenship.
Subject(s)
Alcohol-Related Disorders/nursing , Alcoholism/nursing , Nurse's Role , Nurse-Patient Relations , Nursing Assessment/methods , Temperance/psychology , Adaptation, Psychological , Alcohol-Related Disorders/prevention & control , Alcohol-Related Disorders/rehabilitation , Alcoholism/psychology , Alcoholism/rehabilitation , Clinical Competence , Health Education/methods , Humans , Recurrence , Self ConceptABSTRACT
The approval in 2003 for the use of buprenorphine in opiate addiction treatment has provided physicians with a new pharmacological tool to combat opiate addiction. We surveyed a sample of 100 inpatients who completed short-term opiate detoxification treatment utilizing a combination of buprenorphine and clonidine to assess patient perspectives regarding the usefulness and tolerability of this medication regimen and to compare it to their past opiate detox experiences, if any. Patients identified pain (63%), sleep problems (57%), and anxiety (56%) as the symptoms they perceived to be most helped with buprenorphine. Over 90% of patients with past detoxification treatments rated buprenorphine treatment to be as good as or better than their past treatments. Reports of a euphoric effect were minimal (7%) and no patients reported any generalized worsening of their opiate withdrawal symptoms. We conclude that based upon patient perspectives that combining buprenorphine with clonidine is a useful and well-tolerated medication regimen for the treatment of opiate withdrawal.
